Cubist Systematic Strategies, LLC Castle Biosciences Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 190,570 shares of CSTL stock, worth $4.75 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

190,570

Previous 92,475 106.08%

Holding current value

$4.75 Million

Previous $2.01 Million 170.0%

% of portfolio

0.03%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $1.71 Million - $3.09 Million	98,095 Added 106.08%	190,570 $5.44 Million
Q2 2024 Aug 14, 2024	BUY	$18.84 - $24.94 $202,172 - $267,631	10,731 Added 13.13%	92,475 $2.01 Million
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $208,195 - $291,658	11,528 Added 16.42%	81,744 $1.81 Million
Q4 2023 Feb 14, 2024	SELL	$12.19 - $22.43 $808,452 - $1.49 Million	-66,321 Reduced 48.57%	70,216 $1.52 Million
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $1.18 Million - $1.8 Million	88,647 Added 185.11%	136,537 $2.31 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $148,933 - $332,098	12,773 Added 36.37%	47,890 $657,000
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $32,768 - $47,948	1,683 Added 5.03%	35,117 $797,000
Q4 2022 Feb 14, 2023	SELL	$18.08 - $30.0 $364,474 - $604,770	-20,159 Reduced 37.61%	33,434 $787,000
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $1.88 Million - $2.87 Million	-83,637 Reduced 60.95%	53,593 $1.4 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $1.64 Million - $4.71 Million	102,397 Added 293.97%	137,230 $3.01 Million
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $156,164 - $221,181	-4,708 Reduced 11.91%	34,833 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $1.29 Million - $2.22 Million	32,913 Added 496.58%	39,541 $1.7 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $54,357 - $70,150	904 Added 15.79%	6,628 $441,000
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $169,086 - $259,286	-3,377 Reduced 37.11%	5,724 $420,000
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $263,843 - $435,843	4,478 Added 96.86%	9,101 $623,000
Q4 2020 Feb 16, 2021	SELL	$43.6 - $73.05 $596,927 - $1 Million	-13,691 Reduced 74.76%	4,623 $310,000
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $681,803 - $922,127	17,723 Added 2998.82%	18,314 $942,000
Q2 2020 Aug 14, 2020	SELL	$27.28 - $43.01 $41,165 - $64,902	-1,509 Reduced 71.86%	591 $22,000
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $48,468 - $74,613	2,100 New	2,100 $63,000

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $656M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Castle Biosciences Inc Transaction History